(Q35140561)

6 August 2017

1 reference

title

Breast cancer: when proteomics challenges biological complexity (English)

1 reference

6 August 2017

1 reference

Hubert Hondermarck

1

1 reference

6 August 2017

publication date

29 May 2003

1 reference

Molecular & Cellular Proteomics

6 August 2017

published in

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

281-291

1 reference

Proteomics: new perspectives, new biomedical opportunities

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Proteomics in translational cancer research: toward an integrated approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Molecular markers for predicting response to tamoxifen in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Herceptin: from the bench to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Growth Factor Synthesis and Human Breast Cancer Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Autocrine and paracrine growth inhibitors of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Specific polypeptide differences in normal versus malignant human breast tissues by two-dimensional electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Analysis of polypeptide expression in benign and malignant human breast lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Roads leading to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

14-3-3 proteins: structure, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

The product of the H19 gene may function as an RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Redox regulation of cellular activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Tumor necrosis factor receptor-associated death domain protein is involved in the neurotrophin receptor-mediated antiapoptotic activity of nerve growth factor in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Early changes in protein synthesis induced by basic fibroblast growth factor, nerve growth factor, and epidermal growth factor in PC12 pheochromocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Signaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

The mitogenic signaling pathway for fibroblast growth factor-2 involves the tyrosine phosphorylation of cyclin D2 in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Role of the heat shock response and molecular chaperones in oncogenesis and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Structure and in vivo function of Hsp90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R300003-MCP200

10.1074/MCP.R300003-MCP200

21 January 2018

Identifiers

DOI

0 references

1 reference